Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
Open accessPublished version of a preprint
Abstract
Abstract One major hurdle to the success of adoptive T-cell therapy is the identification of antigens that permit effective targeting of tumors in the absence of toxicities to essential organs. Previous work has demonstrated that T cells engineered to express chimeric antigen receptors (CAR-T cells) targeting the murine homolog of the colorectal cancer antigen GUCY2C treat established colorectal cancer metastases, without toxicity to the normal GUCY2C-expressing intestinal epithelium, reflecting structural compartmentalization of endogenous GUCY2C to apical membranes comprising the intestinal lumen. Here, we examined the utility of a human-specific, GUCY2C-directed single-chain variable fragment as the basis for a CAR construct targeting human GUCY2C-expressing metastases. Human GUCY2C-targeted murine CAR-T cells promoted antigen-dependent T-cell activation quantified by activation marker upregulation, cytokine production, and killing of GUCY2C-expressing, but not GUCY2C-deficient, cancer cells in vitro. GUCY2C CAR-T cells provided long-term protection against lung metastases of murine colorectal cancer cells engineered to express human GUCY2C in a syngeneic mouse model. GUCY2C murine CAR-T cells recognized and killed human colorectal cancer cells endogenously expressing GUCY2C, providing durable survival in a human xenograft model in immunodeficient mice. Thus, we have identified a human GUCY2C-specific CAR-T cell therapy approach that may be developed for the treatment of GUCY2C-expressing metastatic colorectal cancer. Cancer Immunol Res; 6(5); 509–16. ©2018 AACR.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several antigens being evaluated as candidates for anti-CRC CAR-T cell therapy have shown efficacy in CRC preclinical models, including carcinoembryonic antigen and guanylyl cyclase 2C.
“Several antigens being evaluated as candidates for anti-CRC CAR-T cell therapy have shown efficacy in CRC preclinical models, including carcinoembryonic antigen and guanylyl cyclase 2C [227,228].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [227]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413 · see citing works
Lee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898 · see citing works
Morgan, R. A., Yang, J. C.-H., Kitano, M., Dudley, M. E., Laurençot, C. M., & Rosenberg, S. A. (2010) · Molecular Therapy · doi:10.1038/mt.2010.24 · Cited by 2,542 · see citing works
Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., Kotb, M., Gillies, S. D., King, M., Mangada, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6477 · Cited by 1,736 · see citing works
Louis, C. U., Savoldo, B., Dotti, G., Pulè, M. A., Yvon, E. S., Myers, G. D., Rössig, C., Russell, H. V., Diouf, O., Liu, E., et al. (2011) · Blood · doi:10.1182/blood-2011-05-354449 · Cited by 1,162 · see citing works
Gattinoni, L., Finkelstein, S. E., Klebanoff, C. A., Antony, P. A., Palmer, D. C., Spiess, P. J., Hwang, L. N., Yu, Z., Wrzesinski, C., Heimann, D. M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050732 · Cited by 1,063 · see citing works
Parkhurst, M. R., Yang, J. C.-H., Langan, R. C., Dudley, M. E., Nathan, D.-A. N., Feldman, S. A., Davis, J. L., Morgan, R. A., Merino, M. J., Sherry, R. M., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.272 · Cited by 1,025 · see citing works
Beatty, G. L., Haas, A. R., Maus, M. V., Torigian, D. A., Soulen, M. C., Plesa, G., Chew, A., Zhao, Y., Levine, B. L., Albelda, S. Μ., et al. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0170 · Cited by 880 · see citing works
Mulé, J. J., Shu, S., Schwarz, S. L., & Rosenberg, S. A. (1984) · Science · doi:10.1126/science.6332379 · Cited by 688 · see citing works
Liu, X., Jiang, S., Fang, C., Yang, S., Olalere, D., Pequignot, E. C., Cogdill, A. P., Li, N., Ramones, M., Granda, B. W., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0159 · Cited by 583 · see citing works
Huang, A. Y.-C., Gulden, P. H., Woods, A. S., Thomas, M. C., Tong, C., Wang, W., Engelhard, V. H., Pasternack, G. R., Cotter, R. J., Hunt, D. F., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9730 · Cited by 386 · see citing works
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
Muranski, P. J., Boni, A., Wrzesinski, C., Citrin, D. E., Rosenberg, S. A., Childs, R. W., & Restifo, N. P. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0666 · Cited by 358 · see citing works
Carrithers, S. L., Barber, M. T., Biswas, S. B., Parkinson, S. J., Park, P. K., Goldstein, S. D., & Waldman, S. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14827 · Cited by 207 · see citing works
Self-citationHung, A. C. F. (1996) · Medical Entomology and Zoology · Cited by 206 · see citing works
Entering the mainstream of cancer treatment
Rosenberg, S. A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.174 · Cited by 167 · see citing works
A uroguanylin-GUCY2C endocrine axis regulates feeding in mice
Valentino, M. A., Lin, J. E., Snook, A. E., Li, P., Kim, G. W., Marszalowicz, G. P., Magee, M. S., Hyslop, T., Schulz, S., & Waldman, S. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57925 · Cited by 143 · see citing works
Self-citationBirbe, R., Palazzo, J., Walters, R., Weinberg, D. S., Schulz, S., & Waldman, S. A. (2005) · Human Pathology · doi:10.1016/j.humpath.2004.12.002 · Cited by 128 · see citing works
Self-citationEpithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment
Coradini, D., Casarsa, C., & Oriana, S. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.20 · Cited by 101 · see citing works
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
Magee, M. S., Kraft, C. L., Abraham, T. S., Baybutt, T. R., Marszalowicz, G. P., Li, P., Waldman, S. A., & Snook, A. E. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1227897 · Cited by 87 · see citing works
Self-citationThe Putative Tumor Suppressor Cdx2 Is Overexpressed by Human Colorectal Adenocarcinomas
Witek, M. E., Nielsen, K. C., Walters, R., Hyslop, T., Palazzo, J., Schulz, S., & Waldman, S. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1624 · Cited by 82 · see citing works
Self-citationKühn, M., Adermann, K., Jähne, J., Forssmann, W., & Rechkemmer, G. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020307 · Cited by 65 · see citing works
Wolfe, H. R., Mendizabal, M., Leong, E., Cuthbertson, A., Desai, V. C., Pullan, S., Fujii, D. K., Morrison, M. S., Pither, R. J., & Waldman, S. A. (2002) · PubMed · Cited by 53 · see citing works
Self-citationGuarino, A., Cohen, M. B., Overmann, G. J., Thompson, M. R., & Giannella, R. A. (1987) · Digestive Diseases and Sciences · doi:10.1007/bf01297193 · Cited by 52 · see citing works
Xu, X., Song, D.-G., Poussin, M., Ye, Q., Sharma, P., Rodríguez-García, A., Tang, Y., & Powell, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.10510 · Cited by 51 · see citing works
Suicide Gene Therapy to Increase the Safety of Chimeric Antigen Receptor-Redirected T Lymphocytes
Casucci, M., & Bondanza, A. (2011) · Journal of Cancer · doi:10.7150/jca.2.378 · Cited by 50 · see citing works
Snook, A. E., Magee, M. S., Schulz, S., & Waldman, S. A. (2014) · European Journal of Immunology · doi:10.1002/eji.201444539 · Cited by 40 · see citing works
Self-citationSnook, A. E., Li, P., Stafford, B. J., Faul, E. J., Huang, L., Birbe, R., Bombonati, A., Schulz, S., Schnell, M. J., Eisenlohr, L. C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3386 · Cited by 39 · see citing works
Self-citationGuanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer
Aka, A. A., Rappaport, J. A., Pattison, A. M., Sato, T., Snook, A. E., & Waldman, S. A. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1292124 · Cited by 35 · see citing works
Self-citationCharney, A. N., Egnor, R. W., Alexander-Chacko, J. T., Zaharia, V., Mann, E. A., & Giannella, R. A. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.2.g216 · Cited by 29 · see citing works
Polarized Apical Sorting of Guanylyl Cyclase C is Specified by a Cytosolic Signal
Hodson, C. A., Ambrogi, I. G., Scott, R. O., Mohler, P. J., & Milgram, S. L. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00398.x · Cited by 28 · see citing works
GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer
Marszalowicz, G. P., Snook, A. E., Magee, M. S., Merlino, D. J., Berman-Booty, L. D., & Waldman, S. A. (2014) · Oncotarget · doi:10.18632/oncotarget.2455 · Cited by 28 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Martinez, M. C., & Moon, E. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00128 · Cited by 865 · see citing works
Metastatic colorectal cancer: mechanisms and emerging therapeutics
Shin, A. E., Giancotti, F. G., & Rustgi, A. K. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.01.003 · Cited by 692 · see citing works
CAR T cells in solid tumors: challenges and opportunities
Marofi, F., Motavalli, R., Safonov, V. A., Thangavelu, L., Yumashev, A. V., Alexander, M., Shomali, N., Chartrand, M. S., Pathak, Y., Jarahian, M., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02128-1 · Cited by 582 · see citing works
Colorectal Cancer Immunotherapy: Options and Strategies
Johdi, N. A., & SUKOR, N. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01624 · Cited by 469 · see citing works
Adoptive cellular therapies: the current landscape
Rohaan, M. W., Wilgenhof, S., & Haanen, J. B. A. G. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2484-0 · Cited by 400 · see citing works
Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review
Kumar, A., Gautam, V., Sandhu, A., Rawat, K., Sharma, A., & Saha, L. (2023) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v15.i4.495 · Cited by 272 · see citing works
Advances in immunotherapy for colorectal cancer: a review
Golshani, G. M., & Zhang, Y. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820917527 · Cited by 239 · see citing works
LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription
Xiu, B., Chi, Y., Liu, L., Chi, W., Zhang, Q., Chen, J., Guo, R., Si, J., Li, L., Xue, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1115-y · Cited by 209 · see citing works
Dagar, G., Gupta, A., Masoodi, T., Nisar, S., Merhi, M., Hashem, S., Chauhan, R., Dagar, M., Mirza, S., Bagga, P., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04292-3 · Cited by 226 · see citing works
Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors
Chen, T. R., Wang, M., Chen, Y., & Liu, Y. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03315-3 · Cited by 165 · see citing works
Alnefaie, A., Albogami, S. M., Asiri, Y. A., Ahmad, T., Alotaibi, S. S., Al-Sanea, M. M., & Althobaiti, H. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.797440 · Cited by 163 · see citing works
Current status of immunotherapy in metastatic colorectal cancer
Wróbel, P., & Ahmed, S. (2018) · International Journal of Colorectal Disease · doi:10.1007/s00384-018-3202-8 · Cited by 143 · see citing works
Advancements in combining targeted therapy and immunotherapy for colorectal cancer
Singh, M., Morris, V. K., Bandey, I. N., Hong, D. S., & Kopetz, S. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.05.001 · Cited by 138 · see citing works
Reactions Related to CAR-T Cell Therapy
Miao, L., Zhang, Z., Ren, Z., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663201 · Cited by 127 · see citing works
Wang, Y., Zhong, X., He, X., Hu, Z., Huang, H., Chen, J., Chen, K., Zhao, S., Wei, P., & Li, D. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02729-7 · Cited by 126 · see citing works
CAR-T cells and BiTEs in solid tumors: challenges and perspectives
Edeline, J., Houot, R., Marabelle, A., & Alcantara, M. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01067-5 · Cited by 115 · see citing works
Systemic treatment for metastatic colorectal cancer
Leowattana, W., Leowattana, P., & Leowattana, T. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i10.1569 · Cited by 111 · see citing works
Feng, Z., He, X., Zhang, X., Wu, Y., Xing, B., Knowles, A., Shan, Q., Miller, S. I., Hojnacki, T., Ma, J., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00344-7 · Cited by 100 · see citing works
Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment
Yu, S., Wang, Y., He, P., Shao, B., Liu, F., Xiang, Z., Yang, T., Zeng, Y., He, T., Ma, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.809304 · Cited by 99 · see citing works
Ζαννίκου, Μ., Duffy, J. T., Levine, R., Seblani, M. D., Liu, Q., Presser, A., Arrieta, V. A., Chen, C. J., Sonabend, A. M., Horbinski, C., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006239 · Cited by 92 · see citing works
Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
Aparicio, C., Belver, M., Enríquez, L., Espeso, F., Núñez, L., Sánchez, A., de la Fuente, M. Á., & González‐Vallinas, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111781 · Cited by 86 · see citing works
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82 · see citing works
“Several antigens being evaluated as candidates for anti-CRC CAR-T cell therapy have shown efficacy in CRC preclinical models, including carcinoembryonic antigen and guanylyl cyclase 2C [227,228].”
Antitumor activity of NKG2D CAR-T cells against human colorectal cancer cells in vitro and in vivo.
Deng, X., Gao, F., Li, N., Li, Q., Zhou, Y., Yang, T., Cai, Z., Du, P., Chen, F., & Cai, J. (2019) · PubMed Central · Cited by 74 · see citing works
Zhang, B., Liu, J., Mo, Y., Zhang, K., Huang, B., & Shang, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1476904 · Cited by 76 · see citing works
Kreidieh, M., Mukherji, D., Temraz, S. N., & Shamseddine, A. I. (2020) · BioMed Research International · doi:10.1155/2020/9037217 · Cited by 68 · see citing works
Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer
Sur, D. G., Havasi, A. D., Cainap, C. I., Samaşcă, G., Burz, C. C., Bălăcescu, O., Lupan, I., Deleanu, D. M., & Irimie, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010182 · Cited by 67 · see citing works
Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
Qu, C., Zhang, H., Cao, H., Tang, L., Mo, H., Liu, F., Zhang, L., Yi, Z., Long, L., Yan, L., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01669-8 · Cited by 67 · see citing works
Emerging immunotherapies for metastasis
Edwards, S. C., Hoevenaar, W. H. M., & Coffelt, S. B. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01160-5 · Cited by 62 · see citing works
Tolba, M. F. (2020) · International Journal of Cancer · doi:10.1002/ijc.33056 · Cited by 62 · see citing works
Snook, A. E., Baybutt, T. R., Xiang, B., Abraham, T. S., Flickinger, J. C., Hyslop, T., Zhan, T., Kraft, W. K., Sato, T., & Waldman, S. A. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0576-2 · Cited by 62 · see citing works
Self-citationCAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety
Li, H., Yang, C., Cheng, H., Huang, S., & Zheng, Y. (2021) · Journal of Cancer · doi:10.7150/jca.50509 · Cited by 59 · see citing works
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy
Pagotto, S., Simeone, P., Brocco, D., Catitti, G., Bellis, D. D., Vespa, S., Pietro, N. D., Marinelli, L., Stefano, A. D., Veschi, S., et al. (2023) · Cancers · doi:10.3390/cancers15041052 · Cited by 53 · see citing works
Kamrani, A., Nasiri, H., Hassanzadeh, A., Ahmadian Heris, J., Mohammadinasab, R., Sadeghvand, S., Sadeghi, M., Valedkarimi, Z., Hosseinzadeh, R., Shomali, N., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01430-8 · Cited by 50 · see citing works
Recent advances in CAR-T cells therapy for colorectal cancer
Qin, X., Wu, F., Chen, C., & Li, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904137 · Cited by 47 · see citing works
Role of immune checkpoint inhibitors in the treatment of colorectal cancer: focus on nivolumab
Jacome, A. A. D. A., & Eng, C. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1680636 · Cited by 47 · see citing works
Jin, K., Chen, B., Liu, Y., Lan, H., & Yan, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01763-9 · Cited by 46 · see citing works
CAR T-cells for colorectal cancer immunotherapy: Ready to go?
Ghazi, B., Ghanmi, A. E., Kandoussi, S., Ghouzlani, A., & Badou, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978195 · Cited by 47 · see citing works
Ouladan, S., & Orouji, E. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-24-02081 · Cited by 48 · see citing works
Keshavarz, A., Salehi, A., Khosravi, S., Shariati, Y., Nasrabadi, N., Kahrizi, M. S., Maghsoodi, S., Mardi, A., Azizi, R., Jamali, S., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03163-w · Cited by 47 · see citing works
Novel antigens of CAR T cell therapy: New roads; old destination
Kozani, P. S., Kozani, P. S., & Rahbarizadeh, F. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101079 · Cited by 45 · see citing works
Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients
Wang, D., Zhang, H., Xiang, T., & Wang, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.762341 · Cited by 38 · see citing works
Flickinger, J. C., Singh, J., Carlson, R. D., Leong, E., Baybutt, T. R., Barton, J. R., Caparosa, E. M., Pattison, A. M., Rappaport, J. A., Roh, J. W., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001046 · Cited by 40 · see citing works
Self-citationTargeting MSS colorectal cancer with immunotherapy: are we turning the corner?
Wang, C., & Fakih, M. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1933940 · Cited by 36 · see citing works
Zhu, J., Zhou, J., Tang, Y., Huang, R., Lu, C., Ke, Q., Zhou, Q., Zhang, J., Yang, X., Zhou, W., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03938-0 · Cited by 33 · see citing works
Yarla, N. S., Gali, H., Pathuri, G., Smriti, S., Farooqui, M., Panneerselvam, J., Kumar, G., Madka, V., & Rao, C. V. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.011 · Cited by 32 · see citing works
Drougkas, K., Karampinos, K. I., Karavolias, I., Koumprentziotis, I., Ploumaki, I., Triantafyllou, E., Trontzas, I. P., & Kotteas, E. A. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04547-4 · Cited by 30 · see citing works
Combinatorial Immunotherapies for Metastatic Colorectal Cancer
Janssen, E., Subtil, B., Ortiz, F. D. L. J., Verheul, H. M. W., & Tauriello, D. V. F. (2020) · Cancers · doi:10.3390/cancers12071875 · Cited by 30 · see citing works
Chan, L. Y., Dass, S. A., Tye, G. J., Imran, S. A. M., Zaman, W. S. W. K., & Nordin, F. (2022) · Biomedicines · doi:10.3390/biomedicines10040804 · Cited by 33 · see citing works
Díaz‐Basabe, A., Burrello, C., Lattanzi, G., Botti, F., Carrara, A., Cassinotti, E., Caprioli, F., & Facciotti, F. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13104 · Cited by 30 · see citing works
Two distinct GUCY2C circuits with PMV (hypothalamic) and SN/VTA (midbrain) origin
Merlino, D. J., Barton, J. R., Charsar, B. A., Byrne, M. D., Rappaport, J. A., Smeyne, R. J., Lepore, A. C., Snook, A. E., & Waldman, S. A. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01949-y · Cited by 30 · see citing works
Self-citationSilencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia
Bashir, B., Merlino, D. J., Rappaport, J. A., Gnass, E. D., Palazzo, J., Feng, Y., Fearon, E. R., Snook, A. E., & Waldman, S. A. (2019) · Human Pathology · doi:10.1016/j.humpath.2018.11.032 · Cited by 27 · see citing works
Self-citationPrasad, H., Mathew, J. K. K., & Visweswariah, S. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.911459 · Cited by 26 · see citing works
Cell Therapy as Target Therapy against Colon Cancer Stem Cells
Garza Treviño, E. N., Quiroz Reyes, A. G., Rojas Murillo, J. A., de la Garza Kalife, D. A., Delgado Gonzalez, P., Islas, J. F., Estrada Rodriguez, A. E., & Gonzalez Villarreal, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098163 · Cited by 24 · see citing works
Zhu, C., Liao, J.-Y., Liu, Y., Chen, Z., Chang, R.-Z., Chen, X., Zhang, B., & Liang, J.-N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02171-z · Cited by 26 · see citing works
Evaluation of CAR-T cell cytotoxicity: Real-time impedance-based analysis
Lisby, A., Carlson, R. D., Baybutt, T. R., Weindorfer, M., & Snook, A. E. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2021.08.002 · Cited by 24 · see citing works
Self-citationCAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells
Dezfouli, A. B., Yazdi, M., Benmebarek, M.-R., Schwab, M., Michaelides, S., Micciché, A., Geerts, D., Stangl, S., Klapproth, S., Wagner, E., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883694 · Cited by 23 · see citing works
Cao, Y., Efetov, S. K., He, M., Fu, Y., Beeraka, N. M., Zhang, J., Zhang, X., Bannimath, N., & Chen, K. (2023) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-023-00684-x · Cited by 24 · see citing works
Yoo, H. J., & Harapan, B. N. (2021) · Immunologic Research · doi:10.1007/s12026-021-09236-x · Cited by 23 · see citing works
CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets
Maher, J. F., & Davies, D. M. (2023) · Cancers · doi:10.3390/cancers15041171 · Cited by 22 · see citing works
Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy
Staudt, R. E., Carlson, R. D., & Snook, A. E. (2022) · Cancer Biology & Therapy · doi:10.1080/15384047.2022.2033057 · Cited by 21 · see citing works
Self-citationEntezari, A. A., Snook, A. E., & Waldman, S. A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1937124 · Cited by 20 · see citing works
Self-citationInteraction between gut microbiota and T cell immunity in colorectal cancer
Jing, Z., Wu, Y., Chu, J., Zhanbo, Q., Wu, X., & Han, S. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103807 · Cited by 19 · see citing works
The updates on metastatic mechanism and treatment of colorectal cancer
Ni, Y., Liang, Y., Li, M., Lin, Y., Zou, X., 韩芳毅, Cao, J., & Li, L. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154837 · Cited by 20 · see citing works
Development of chimeric antigen receptor-modified T cells for the treatment of esophageal cancer
Yu, F., Wang, X., Shi, H. M., Jiang, M., Xu, J., Sun, M., Xu, Q., Addai, F. P., Shi, H., Gu, J., et al. (2020) · Tumori Journal · doi:10.1177/0300891620960223 · Cited by 19 · see citing works
Qi, C., Liu, D., Liu, C., Wei, X., Ma, M., Lu, X., Tao, M., Zhang, C., Wang, X., He, T., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009960 · Cited by 18 · see citing works
GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer
Lisby, A., Flickinger, J. C., Bashir, B., Weindorfer, M., Shelukar, S., Crutcher, M. M., Snook, A. E., & Waldman, S. A. (2021) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2021.1876518 · Cited by 18 · see citing works
Self-citation“Hurdles race for CAR T ‐cell therapy in digestive tract cancer”
Kronig, M.-N., Wehrli, M., Salas‐Benito, D., & Maus, M. V. (2023) · Immunological Reviews · doi:10.1111/imr.13273 · Cited by 18 · see citing works
Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?
Lin, Y., Kong, D.-X., & Zhang, Y.-N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.852194 · Cited by 17 · see citing works
Flickinger, J. C., Staudt, R. E., Singh, J., Carlson, R. D., Barton, J. R., Baybutt, T. R., Rappaport, J. A., Zalewski, A., Pattison, A. M., Waldman, S. A., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00483-z · Cited by 16 · see citing works
Self-citationRathinavel, T., Vasuki, S., Sindhu, S. M., Mothilal, T. M., Srimathi, V., Poornima, B., Bhuvaneswari, M., & Hariharan, M. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01090-0 · Cited by 15 · see citing works
Recent advances and progress in immunotherapy of solid cancers
Kumar, A., Emdad, L., Das, S. K., & Fisher, P. B. (2024) · Advances in cancer research · doi:10.1016/bs.acr.2024.05.004 · Cited by 15 · see citing works
Emerging drug targets for colon cancer: A preclinical assessment
Crutcher, M. M., Baybutt, T. R., Kopenhaver, J. S., Snook, A. E., & Waldman, S. A. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2039119 · Cited by 15 · see citing works
Self-citationAdvances in adoptive cellular therapy for colorectal cancer: A narrative review
Yi, X., & Hu, W. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-6196 · Cited by 14 · see citing works
Immunotherapy in colorectal cancer treatment: actual landscape and future perspectives
Bittoni, A., Sotte, V., Meletani, T., Cantini, L., Giampieri, R., & Berardi, R. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.37 · Cited by 14 · see citing works
Stem Cells as Therapeutic Targets in Colorectal Cancer
Zalewski, A., Snook, A. E., & Waldman, S. A. (2021) · Personalized Medicine · doi:10.2217/pme-2020-0099 · Cited by 14 · see citing works
Self-citationChinese consensus on prevention of colorectal neoplasia (2021, S hanghai)
Fang, J.-Y. (2022) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13079 · Cited by 14 · see citing works
Zhang, W., Zhang, J., Liu, T., Xing, J., Zhang, H., Wang, D., & Tang, D. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04081-3 · Cited by 14 · see citing works
Pro-tumorigenic role of type 2 diabetes-induced cellular senescence in colorectal cancer
Melia, F., Udomjarumanee, P., Zinovkin, D. A., Arghiani, N., & Pranjol, M. Z. I. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.975644 · Cited by 14 · see citing works
Antibody Fragment and Targeted Colorectal Cancer Therapy: A Global Systematic Review
Ghani, S., Deravi, N., Pirzadeh, M., Rafiee, B., Gatabi, Z. R., Bandehpour, M., & Yarian, F. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210810104226 · Cited by 13 · see citing works
CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer
Li, M., Li, S., Zhao, R., Lv, J., Zheng, D., Qin, L., Li, S., Wu, Q., Long, Y., Tang, Z., et al. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00967-1 · Cited by 13 · see citing works
Translational research of new developments in targeted therapy of colorectal cancer
Yang, L., Atakhanova, N. E., Arellano, M. T. C., Mohamed, M. Y., Hani, T., Fahdil, A. A., Castillo-Acobo, R. Y., Juyal, A., Hussein, A. K., Amin, A. H., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154888 · Cited by 14 · see citing works
Mandriani, B., Pellè, E., Pezzicoli, G., Strosberg, J., Abate‐Daga, D., Guarini, A., Cives, M., & Porta, C. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102288 · Cited by 13 · see citing works
Wang, H., & Pan, W. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04568-0 · Cited by 12 · see citing works
CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy
Baybutt, T. R., Entezari, A. A., Caspi, A., Staudt, R. E., Carlson, R. D., Waldman, S. A., & Snook, A. E. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2398801 · Cited by 14 · see citing works
Self-citationRappaport, J. A., & Waldman, S. A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1826304 · Cited by 12 · see citing works
Self-citationSrivastava, S., Tyagi, A., Pawar, V. A., Khan, N. H., Arora, K., Verma, C., & Kumar, V. (2024) · ImmunoTargets and Therapy · doi:10.2147/itt.s474659 · Cited by 11 · see citing works
Cell-Based Therapies in GI Cancers: Current Landscape and Future Directions
Nakayama, I., & Shitara, K. (2025) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk-25-471716 · Cited by 12 · see citing works
Khorasani, A. B. S., Sanaei, M., Pourbagheri‐Sigaroodi, A., Ghaffari, S. H., & Bashash, D. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108260 · Cited by 10 · see citing works
Chen, K., Huang, B., Yan, S., Xu, S., Li, K., Zhang, K., Wang, Q., Zhuang, Z., Wei, L., Zhang, Y., et al. (2020) · Aging · doi:10.18632/aging.103923 · Cited by 9 · see citing works
Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer
Caspi, A., Entezari, A. A., Crutcher, M. M., Snook, A. E., & Waldman, S. A. (2022) · Personalized Medicine · doi:10.2217/pme-2022-0026 · Cited by 9 · see citing works
Self-citationIntestinal Microbiota: The Driving Force behind Advances in Cancer Immunotherapy
Dai, Z., Fu, J., Peng, X., Tang, D., & Song, J. (2022) · Cancers · doi:10.3390/cancers14194796 · Cited by 8 · see citing works
Progress of research on γδ T cells in colorectal cancer (Review)
Pan, L., Zhou, Y., Kuang, Y., Wang, C., Wang, W., Hu, X., & Chen, X. (2024) · Oncology Reports · doi:10.3892/or.2024.8819 · Cited by 7 · see citing works
Piroozkhah, M., Aghajani, A., Jalali, P., Shahmoradi, A., Piroozkhah, M., Tadlili, Y., & Salehi, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1277265 · Cited by 7 · see citing works
Azizi, A. A., Pillai, M. R., & Thistlethwaite, F. C. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000562 · Cited by 7 · see citing works
Li, J., Fu, Y., Zhang, K., & Li, Y. (2022) · Vaccines · doi:10.3390/vaccines10091562 · Cited by 7 · see citing works
Li, H., Guo, L., Wang, C., Hu, X., & Xu, Y. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0293 · Cited by 7 · see citing works
Gene Coexpression and miRNA Regulation: A Path to Early Intervention in Colorectal Cancer
Huang, J. C., Li, M., Huang, I.-C., Hu, J.-M., Lin, W.-Z., & Chang, Y.-T. (2024) · Human Gene Therapy · doi:10.1089/hum.2023.207 · Cited by 6 · see citing works
Gila, F., Khoddam, S., Jamali, Z., Ghasemian, M., Shakeri, S., Dehghan, Z., & Fallahi, J. (2025) · Personalized Medicine · doi:10.1080/17410541.2025.2459050 · Cited by 6 · see citing works
Promising immunotherapeutic treatments for colon cancer
Gutiu, A. G., Zhao, L., Marrah, A. J., Maher, A. J., Voss, B., Mayberry, T. G., Cowan, B. C., Wakefield, M. R., & Fang, Y. (2025) · Medical Oncology · doi:10.1007/s12032-025-02724-2 · Cited by 6 · see citing works
CAR cell design strategies in solid tumors.
Wang, L., Chen, X., Zhang, L., Niu, B.-N., Li, L., Sun, Y., & Yuan, X.-L. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109345 · Cited by 7 · see citing works
- Authors
- Magee, M. S., Abraham, T. S., Baybutt, T. R., Flickinger, J. C., Ridge, N. A., Marszalowicz, G. P., Prajapati, P., Hersperger, A. R., Waldman, S. A., & Snook, A. E.
- Affiliations
- Thomas Jefferson University (US)
- Drexel University (US)
- Corresponding author
- Snook, Adam E.
- ORCID
- Venue
- Cancer Immunology Research
- Published
- 2018-04-30
- Volume
- 6
- Issue
- 5
- Pages
- 509-516
- ISSN
- 2326-6066 (ISSN-L)
- 2326-6074
- PMC
- PMC5932207
- OpenAlex
- W2796020321
- Cited by
- 143
- References
- 31
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 15 · 2023: 23 · 2022: 31 · 2021: 22 · 2020: 14 · 2019: 10 · 2018: 5
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Immunology Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- The Medicine Forum (submittedVersion)
- Funders
- NIH (P30 CA56036, R01 CA204881, R01 CA206026, F31 CA171672)
- Pennsylvania Department of Health (SAP #4100059197, SAP #4100051723)
- Topics
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Cancer Research and Treatments
- Keywords
- GUCY2C, chimeric antigen receptor T cells, CAR T-cell therapy, colorectal cancer metastasis, lung metastasis, scFv, tumor antigen targeting, intestinal epithelium, xenograft models, adoptive T cell therapy
- MeSH terms
- Receptors, Enterotoxin, Receptors, Chimeric Antigen, Animals, Cells, Cultured, Cytotoxicity, Immunologic, Humans, Lung Neoplasms, Mice, Inbred BALB C, Mice, Transgenic, Neoplasm Metastasis, Receptors, Antigen, T-Cell, T-Lymphocytes, Colorectal Neoplasms, Immunotherapy, Adoptive, Xenograft Model Antitumor Assays, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
